platinum has been researched along with adamantane in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brabec, V; Intini, F; Kaspárková, J; Natile, G; Nováková, O; Vrána, O | 1 |
| Bandyopadhyay, D; Dabrowiak, JC; Luk, YY; Prashar, D; Shi, Y | 1 |
| Cerrada, E; Fröhlich, N; Guerrero, E; Koenen, JM; Laguna, M; Lüttenberg, S; Mendía, A; Miranda, S; Mohr, F | 1 |
| Bergamini, P; Ferretti, V; Fogagnolo, M; Marchi, A; Marvelli, L; Sforza, F | 1 |
| Bergamini, P; Cortesi, R; Damiani, C; Drechsler, M; Esposito, E; Mariani, P; Marvelli, L; Pagnoni, A; Ravani, L; Sforza, F | 1 |
| Bergamini, P; Carducci, F; Cortesi, R; Drechsler, M; Esposito, E; Gallerani, E; Gavioli, R; Mariani, P; Marvelli, L; Sguizzato, M | 1 |
6 other study(ies) available for platinum and adamantane
| Article | Year |
|---|---|
Molecular aspects of antitumor effects of a new platinum(IV) drug.
Topics: Adamantane; Animals; Antineoplastic Agents; Ascorbic Acid; Base Sequence; Cell Line, Tumor; Cell-Free System; Cross-Linking Reagents; DNA; DNA Adducts; DNA Repair; DNA-Directed RNA Polymerases; HeLa Cells; High Mobility Group Proteins; HIV-1; Humans; Molecular Sequence Data; Neoplasms; Organoplatinum Compounds; Plasmids; Platinum; Rats; RNA-Directed DNA Polymerase; Sulfur Compounds; Viral Proteins | 2006 |
Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification.
Topics: Adamantane; Antineoplastic Agents; beta-Cyclodextrins; Carboplatin; Cell Line, Tumor; Cell Survival; Drug Carriers; Fluorescein-5-isothiocyanate; Humans; Mass Spectrometry; Microscopy, Confocal; Plasmids; Platinum | 2011 |
trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
Topics: Adamantane; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Palladium; Platinum; Solubility; Structure-Activity Relationship; Sulfhydryl Compounds; Water | 2013 |
Acetylcholine-like and trimethylglycine-like PTA (1,3,5-triaza-7-phosphaadamantane) derivatives for the development of innovative Ru- and Pt-based therapeutic agents.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Platinum; Ruthenium; Structure-Activity Relationship | 2014 |
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studies.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; DNA; Humans; Lipids; Nanoparticles; Organophosphorus Compounds; Platinum | 2015 |
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (II) carboxylates.
Topics: Adamantane; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Carriers; Emulsions; Humans; K562 Cells; Lipids; Magnetic Resonance Spectroscopy; Nanoparticles; Organophosphorus Compounds; Particle Size; Platinum; Stearic Acids | 2017 |